Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
2.

Citicoline: pharmacological and clinical review, 2006 update.

Secades JJ, Lorenzo JL.

Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Review.

PMID:
17171187
3.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
4.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
5.

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG.

Int J Geriatr Psychiatry. 2004 Jul;19(7):624-33. Review.

PMID:
15254918
6.
7.
8.

Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.

Grossberg GT, Schmitt FA, Meng X, Tekin S, Olin J.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):627-33. doi: 10.1177/1533317510385808. Review.

PMID:
21131668
9.

Citicoline, use in cognitive decline: vascular and degenerative.

García-Cobos R, Frank-García A, Gutiérrez-Fernández M, Díez-Tejedor E.

J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27. Review.

PMID:
20875651
12.

[Alzheimer dementia and normal aging. Clinical, neuroradiologic, neurophysiologic and molecular biology follow-up data].

Förstl H, Sattel H, Sarochan M, Besthom C, Czech C, Daniel S, Geiger-Kabisch C, Hentschel F, Zerfass R, Beyreuther K.

Nervenarzt. 1996 Sep;67(9):730-8. Review. German.

PMID:
8992370
13.

Citicoline in vascular cognitive impairment and vascular dementia after stroke.

Alvarez-Sabín J, Román GC.

Stroke. 2011 Jan;42(1 Suppl):S40-3. doi: 10.1161/STROKEAHA.110.606509. Epub 2010 Dec 16. Review.

14.

The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease.

Pasquier F, Leys D, Scheltens P.

J Neural Transm Suppl. 1998;54:117-27. Review.

PMID:
9850920
15.

Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.

Poirier J, Sévigny P.

J Neural Transm Suppl. 1998;53:199-207. Review.

PMID:
9700658
16.

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Wagstaff AJ, McTavish D.

Drugs Aging. 1994 Jun;4(6):510-40. Review. Erratum in: Drugs Aging 1994 Aug;5(2):95.

PMID:
7521234
17.

Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.

Secades JJ, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Martínez-Vila E, Ríos J, Oudovenko N.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1984-96. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.010. Epub 2016 May 24. Review.

PMID:
27234918
18.

Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging.

de la Torre JC.

Gerontology. 1997;43(1-2):26-43. Review.

PMID:
8996828
19.

NGF and the treatment of Alzheimer's disease.

Olson L.

Exp Neurol. 1993 Nov;124(1):5-15. Review.

PMID:
8282080
20.

Lecithin and memory training in suspected Alzheimer's disease.

Brinkman SD, Smith RC, Meyer JS, Vroulis G, Shaw T, Gordon JR, Allen RH.

J Gerontol. 1982 Jan;37(1):4-9. Review.

PMID:
7031118

Supplemental Content

Support Center